AIM
TEVA icon

Axiom Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Axiom Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Sell
30,232
-1,800
-6% -$60K 0.68% 40
2026
Q1 		$965K Buy
+32,032
New +$1.03M 0.73% 37
2022
Q4 		– Sell
-10
Closed – – 402
2022
Q3 		$0 Buy
+10
New +$88 ﹤0.01% 458

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Axiom Investment Management's TEVA Position: Q2 2026 in Review

Axiom Investment Management reduced its Teva Pharmaceuticals (TEVA) stake by 5.6% in Q2 2026, selling an estimated $60K and leaving 30,232 shares worth $1.02M. The position accounts for 0.68% of the portfolio, ranked #40.

Axiom Investment Management first reported a position in TEVA in Q3 2022 and has held it in 3 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Axiom Investment Management held 30,232 shares of Teva Pharmaceuticals worth $1.02M as of Q2 2026.
  • Axiom Investment Management sold 1,800 Teva Pharmaceuticals shares in Q2 2026, an estimated $60K.
  • Teva Pharmaceuticals made up 0.68% of Axiom Investment Management's portfolio in Q2 2026, its #40 holding.
  • Axiom Investment Management first reported a position in Teva Pharmaceuticals in Q3 2022 and has held it in 3 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Axiom Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.